Crossmark Global Holdings’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.7M | Buy |
367,157
+1,395
| +0.4% | +$113K | 0.37% | 63 |
|
|
2026
Q1 | $31.7M | Sell |
365,762
-11,179
| -3% | -$1.07M | 0.47% | 42 |
|
|
2025
Q4 | $36.2M | Buy |
376,941
+20,850
| +6% | +$2.03M | 0.52% | 37 |
|
|
2025
Q3 | $33.9M | Sell |
356,091
-4,691
| -1% | -$431K | 0.51% | 34 |
|
|
2025
Q2 | $31.4M | Buy |
360,782
+1,451
| +0.4% | +$123K | 0.51% | 33 |
|
|
2025
Q1 | $32.3M | Buy |
359,331
+3,923
| +1% | +$351K | 0.57% | 31 |
|
|
2024
Q4 | $28.4M | Buy |
355,408
+18,310
| +5% | +$1.59M | 0.52% | 36 |
|
|
2024
Q3 | $30.3M | Buy |
337,098
+7,683
| +2% | +$646K | 0.54% | 33 |
|
|
2024
Q2 | $25.9M | Buy |
329,415
+2,251
| +0.7% | +$185K | 0.5% | 33 |
|
|
2024
Q1 | $28.5M | Buy |
327,164
+122,176
| +60% | +$10.4M | 0.55% | 26 |
|
|
2023
Q4 | $16.9M | Sell |
204,988
-4,206
| -2% | -$321K | 0.35% | 65 |
|
|
2023
Q3 | $15.9M | Buy |
209,194
+1,522
| +0.7% | +$127K | 0.36% | 57 |
|
|
2023
Q2 | $18.3M | Buy |
207,672
+6,305
| +3% | +$543K | 0.39% | 50 |
|
|
2023
Q1 | $16.2M | Sell |
201,367
-97,664
| -33% | -$7.96M | 0.38% | 58 |
|
|
2022
Q4 | $23.2M | Buy |
299,031
+8,010
| +3% | +$649K | 0.58% | 24 |
|
|
2022
Q3 | $23.5M | Buy |
291,021
+6,681
| +2% | +$600K | 0.65% | 21 |
|
|
2022
Q2 | $25.5M | Buy |
284,340
+5,969
| +2% | +$605K | 0.66% | 22 |
|
|
2022
Q1 | $30.9M | Buy |
278,371
+2,996
| +1% | +$317K | 0.69% | 18 |
|
|
2021
Q4 | $28.5M | Sell |
275,375
-8,911
| -3% | -$1.03M | 0.62% | 22 |
|
|
2021
Q3 | $35.6M | Buy |
284,286
+2,830
| +1% | +$366K | 0.83% | 10 |
|
|
2021
Q2 | $34.9M | Buy |
281,456
+7,919
| +3% | +$994K | 0.82% | 10 |
|
|
2021
Q1 | $32.3M | Buy |
273,537
+2,922
| +1% | +$342K | 0.8% | 13 |
|
|
2020
Q4 | $31.7M | Sell |
270,615
-20,406
| -7% | -$2.25M | 0.8% | 12 |
|
|
2020
Q3 | $30.2M | Sell |
291,021
-13,490
| -4% | -$1.35M | 0.85% | 13 |
|
|
2020
Q2 | $27.9M | Sell |
304,511
-7,738
| -2% | -$742K | 0.81% | 15 |
|
|
2020
Q1 | $28.2M | Buy |
312,249
+1,295
| +0.4% | +$138K | 1.01% | 9 |
|
|
2019
Q4 | $35.3M | Buy |
310,954
+1,749
| +0.6% | +$192K | 0.97% | 8 |
|
|
2019
Q3 | $33.6M | Sell |
309,205
-14,593
| -5% | -$1.52M | 0.98% | 7 |
|
|
2019
Q2 | $31.5M | Sell |
323,798
-1,463
| -0.4% | -$134K | 0.88% | 9 |
|
|
2019
Q1 | $29.6M | Buy |
325,261
+1,915
| +0.6% | +$171K | 0.84% | 11 |
|
|
2018
Q4 | $29.4M | Buy |
323,346
+7,867
| +2% | +$735K | 0.91% | 7 |
|
|
2018
Q3 | $31M | Sell |
315,479
-17,493
| -5% | -$1.62M | 0.79% | 9 |
|
|
2018
Q2 | $28.5M | Sell |
332,972
-566
| -0.2% | -$47.3K | 0.76% | 8 |
|
|
2018
Q1 | $26.8M | Buy |
333,538
+4,349
| +1% | +$359K | 0.69% | 17 |
|
|
2017
Q4 | $26.6M | Buy |
329,189
+13,607
| +4% | +$1.09M | 0.64% | 19 |
|
|
2017
Q3 | $24.5M | Buy |
+315,582
| New | +$26.2M | 0.63% | 20 |
|
|
2016
Q3 | $24.5M | Buy |
+315,582
| New | +$27.5M | 0.63% | 20 |
|
Other funds holding MDT
Crossmark Global Holdings's MDT Position: Q2 2026 in Review
Crossmark Global Holdings increased its Medtronic (MDT) stake by 0.38% in Q2 2026, buying an estimated $113K and bringing the position to 367,157 shares worth $28.7M. The position accounts for 0.37% of the portfolio, ranked #63.
Crossmark Global Holdings first reported a position in MDT in Q3 2016 and has held it in 37 quarters since. The position peaked at $36.2M in Q4 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Crossmark Global Holdings held 367,157 shares of Medtronic worth $28.7M as of Q2 2026.
- Crossmark Global Holdings bought 1,395 Medtronic shares in Q2 2026, an estimated $113K.
- Medtronic made up 0.37% of Crossmark Global Holdings's portfolio in Q2 2026, its #63 holding.
- Crossmark Global Holdings first reported a position in Medtronic in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Medtronic position peaked at $36.2M in Q4 2025.
- 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.